MALAT1 and neoplasm: A signaling pathway of MALAT1/miR-328/KATNB1 was established in our study, which explained the down-regulated KATNB1 mRNA and katanin P80 levels in patients carrying haplotype GGGT and reduced lymph node size in lung cancer and tumor size in brain metastatic lung cancer.